135 related articles for article (PubMed ID: 4107957)
1. Positive correlation of the long-acting thyroid stimulator (LATS) with the percentage of endogenously labelled 131 I triiodothyronine in the plasma of hyperthyroid patients.
Emrich D; Albani M; zur Mühlen A von
Acta Endocrinol (Copenh); 1971 Nov; 68(3):445-50. PubMed ID: 4107957
[No Abstract] [Full Text] [Related]
2. [Clinical studies of long-acting thyroid stimulator].
Eguchi Y
Nihon Naibunpi Gakkai Zasshi; 1970 Nov; 46(8):939-52. PubMed ID: 4099204
[No Abstract] [Full Text] [Related]
3. L.A.T.S. and Graves' disease.
Hedley AJ; Ross IP; Crooks J
Lancet; 1970 Aug; 2(7670):468-9. PubMed ID: 4195146
[No Abstract] [Full Text] [Related]
4. Long-acting thyroid stimulator (LATS) in hyperthyroidism and exophthalmos.
Friis T
Dan Med Bull; 1969 Nov; 16(10):294-304. PubMed ID: 5392781
[No Abstract] [Full Text] [Related]
5. Clinical significance of LATS and TSH in the blood.
Lemarchand-Béraud T; Griessen M; Scazziga BR
Ann Clin Res; 1972 Jun; 4(3):121-37. PubMed ID: 4625026
[No Abstract] [Full Text] [Related]
6. The long-acting thyroid stimulator and the result of I 131 treatment for thyrotoxicosis.
Martin FI; Larkins RG; Alford FP; Andrews JT; Greenberg PB; Melick RA; Penington JS
Aust N Z J Med; 1972 May; 2(2):168-72. PubMed ID: 4116447
[No Abstract] [Full Text] [Related]
7. Observations against a causal relationship between the long-acting thyroid stimulator and ophthalmopathy in Graves' disease.
McKenzie JM; McCullagh EP
J Clin Endocrinol Metab; 1968 Aug; 28(8):1177-82. PubMed ID: 4175472
[No Abstract] [Full Text] [Related]
8. [TSH and the "long-acting thyroid stimulator" (LATS) in patients with compensated hyperthyroidism].
zur Mühlen A von ; Hesch RD; von Lilienfeld H; Emrich D
Acta Endocrinol Suppl (Copenh); 1971; 152():86. PubMed ID: 5313711
[No Abstract] [Full Text] [Related]
9. Thyroid suppression and the long-acting thyroid stimulator following radioactive iodine therapy for thyrotoxicosis.
Alford FP; Larkins RG; Martin FI
Aust N Z J Med; 1971 Nov; 1(4):339-45. PubMed ID: 5292990
[No Abstract] [Full Text] [Related]
10. Dissociation of serum LATS content and thyroid suppressibility during treatment of hyperthyroidism.
Chopra IJ; Solomon DH; Johnson DE; Chopra U; Fischer DA
J Clin Endocrinol Metab; 1970 Apr; 30(4):524-8. PubMed ID: 5435290
[No Abstract] [Full Text] [Related]
11. [Determination of thyrotropic hormone and long acting thyroid stimulator by the McKenzie technique. Critical study of the method].
Bonnyns M
Rev Fr Etud Clin Biol; 1968 Nov; 13(9):845-52. PubMed ID: 5709509
[No Abstract] [Full Text] [Related]
12. Occurrence in thyrotoxicosis of a gamma globulin which protects LATS from neutralization by an extract of thyroid gland.
Adams DD; Kennedy TH
J Clin Endocrinol Metab; 1967 Feb; 27(2):173-7. PubMed ID: 4163610
[No Abstract] [Full Text] [Related]
13. [The long-acting thyroid stimulator (LATS) in untreated and I-131 treated hyperthyreoses, following total thyroidectomy, as well as its relation to thyroid antibodies].
Ziemke A; Weisbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W
Klin Wochenschr; 1968 Oct; 46(19):1025-7. PubMed ID: 5727481
[No Abstract] [Full Text] [Related]
14. Studies on the nature of plasma thyroid stimulating activity in hyperthyroidism.
Hoffman MJ; Mason EK; Good BF; Hetzel BS; Ferguson K
Australas Ann Med; 1967 May; 16(2):98-106. PubMed ID: 4167406
[No Abstract] [Full Text] [Related]
15. The value of IgG separation for the detection of LATS in human serum.
Bonnyns M; Vanhaelst L
Clin Exp Immunol; 1969 May; 4(5):597-601. PubMed ID: 5815122
[TBL] [Abstract][Full Text] [Related]
16. [The long acting thyroid stimulator (LATS) in some thyroid diseases. Preliminary results].
Busnardo B; Accordi F; Debiasi S
Acta Isot (Padova); 1968 Oct; 8(2):165-79. PubMed ID: 5761578
[No Abstract] [Full Text] [Related]
17. Influence of the long-acting thyroid stimulator (LATS) on radioiodine-labelled thyroxine and triiodothyronine in the thyroid of mice.
Emrich D; von Toll-Jürgens KH; zur Mühlen A Von
Endocrinology; 1970 Sep; 87(3):632-6. PubMed ID: 5424582
[No Abstract] [Full Text] [Related]
18. [The determination of long-acting thyroid stimulator (LATS) in thyroid diseases].
Depisch D; Höfer R; Schatz H
Wien Z Inn Med; 1968; 49(4):121-30. PubMed ID: 5757238
[No Abstract] [Full Text] [Related]
19. Relation between thyroid function and serum levels of long-acting thyroid stimulator.
Davis JC; Hipkin LJ; Summers VK; Gimlette TM
Acta Endocrinol (Copenh); 1975 Jul; 79(3):451-8. PubMed ID: 1173501
[TBL] [Abstract][Full Text] [Related]
20. Hypothyroidism after treatment with sodium iodide I-131. Incidence and relationship to antithyroid antibodies, long-acting thyroid stimulator (LATS), and infiltrative ophthalmopathy.
Burke G; Silverstein GE
JAMA; 1969 Nov; 210(6):1051-8. PubMed ID: 4900342
[No Abstract] [Full Text] [Related]
[Next] [New Search]